stockportfolio.pro
Guardian Pharmacy Services, Inc. (GRDN)
Healthcare · Medical Care Facilities · NYSE
Guardian Pharmacy Services, Inc. revenue & earnings — last 4 fiscal years
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $908.91M | $1.05B | $1.23B | $1.45B |
| Gross profit | $185.87M | $208.31M | $244.37M | $292.72M |
| Net income | $35.42M | $23.90M | $-87.29M | $49.22M |
| Net margin | 3.9% | 2.3% | -7.1% | 3.4% |
Source: Guardian Pharmacy Services, Inc. SEC filings (10-K).
What growth is priced into GRDN stock?
At today's market cap of $2.67B, Guardian Pharmacy Services, Inc. is priced for free-cash-flow growth of about 14.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $80.71M from the FY ending 2025-12-31). This is a reverse DCF — a translation of the price into a growth assumption you can judge, not a fair value and not advice. Change the assumptions yourself in the interactive view →
Explore 4 years of Guardian Pharmacy Services, Inc. financials — interactive
Full income statement, balance sheet and cash flow with CAGR and trend on every row, 48 quarters, valuation ratios, plain-English health checks, and Ask — our SEC-grounded research assistant.
Open the interactive view — freeOr start a 7-day free trial to track GRDN in your portfolio →
Guardian Pharmacy Services, Inc. financial history by metric
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
Guardian Pharmacy Services, Inc. — frequently asked questions
What is Guardian Pharmacy Services, Inc.'s revenue?
Guardian Pharmacy Services, Inc. (GRDN) reported revenue of $1.45B for fiscal year 2025, up 17.9% from the prior year, according to its SEC filings.
Is Guardian Pharmacy Services, Inc. profitable?
Yes. GRDN earned net income of $49.22M in fiscal 2025, a net margin of 3.4%.
What is GRDN's P/E ratio?
Guardian Pharmacy Services, Inc. trades at a price-to-earnings ratio of about 50.1 based on the latest data in our nightly-refreshed cache.
How fast is Guardian Pharmacy Services, Inc. growing?
GRDN's revenue grew at roughly 16.8% per year over the last five fiscal years (compound annual growth rate), computed from SEC-filed statements.
How much debt does Guardian Pharmacy Services, Inc. have?
As of fiscal year 2025, GRDN carried roughly $0 in total debt (short- plus long-term borrowings), per its filed balance sheet.
What is Guardian Pharmacy Services, Inc.'s gross margin?
GRDN's gross margin was 20.2% in fiscal 2025 — gross profit of $292.72M on revenue of $1.45B.
What is Guardian Pharmacy Services, Inc.'s market cap?
Guardian Pharmacy Services, Inc. (GRDN) has a market capitalization of about $2.67B, based on the latest data in our nightly-refreshed cache.
When does Guardian Pharmacy Services, Inc.'s fiscal year end?
GRDN's fiscal year ends in December. Its most recent annual filing covers the fiscal year ending 2025-12-31.
What growth is priced into GRDN stock?
At today's market cap of $2.67B, Guardian Pharmacy Services, Inc. is priced for free-cash-flow growth of about 14.5% per year for 10 years (assuming a 10% discount rate and 2.5% terminal growth, base FCF $80.71M from the FY ending 2025-12-31).
Where does this data come from?
All figures are computed from Guardian Pharmacy Services, Inc.'s official SEC filings (10-K and 10-Q), covering 4 years of history, refreshed nightly. stockportfolio.pro does not provide investment advice.